Dr Reddys Laboratories (RDY) FCF Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.55 Bn | 38.89 Bn | 2.15 Bn | 213.00 |
| 2 | Viatris | 19.15 Bn | 18.26 Bn | 1.46 Bn | -291.00 |
| 3 | Dr Reddys Laboratories | 9.87 Bn | 9.70 Bn | 396.53 Mn | -1,879.00 |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.32 Bn | 334.51 Mn | -263.00 |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 1,258.00 |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | 46,147.00 |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 460.00 |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | -824.00 |
| 9 | Fennec Pharmaceuticals | 401.76 Mn | 360.51 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,879.00 |
| Sep 30, 2025 | 567.00 |
| Jun 30, 2025 | 605.00 |
| Sep 30, 2024 | 430.00 |
| Jun 30, 2024 | 1,817.00 |
| Mar 31, 2024 | -558.00 |
| Dec 31, 2023 | -308.00 |
| Sep 30, 2023 | 799.00 |
| Jun 30, 2023 | -244.00 |
| Mar 31, 2023 | 2,411.00 |
| Dec 31, 2022 | 2,113.00 |
| Sep 30, 2022 | -936.00 |
| Jun 30, 2022 | -413.00 |
| Mar 31, 2022 | 257.00 |
| Dec 31, 2021 | -250.00 |
| Sep 30, 2021 | -1,424.00 |
| Jun 30, 2021 | 730.00 |
| Mar 31, 2021 | 718.00 |
| Dec 31, 2020 | -1,420.00 |
| Sep 30, 2020 | -191.00 |